Clinical-stage Biotechnology Company Focused on
Developing Innovative Therapies for Inflammatory Heart Disease
COVID-19 and CVD
Cardiol has been approved by the FDA for a Phase II/III clinical trial to test the efficacy of CardiolRx™ in improving outcomes for COVID-19 patients with cardiovascular disease (CVD).
Latest NewsAll news
October 20, 2020
September 25, 2020